Rare diseases
Investigational molecules
Locations
Back to Poland1 174 clinical trials in Zabrze, Poland across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)A study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa
PolandA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
PolandA Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer
PolandA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
PolandA study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension
PolandA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
PolandA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
PolandA study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema
PolandA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
PolandA study to evaluate the efficacy and safety of etrasimod arginine in children with moderately to severely active ulcerative colitis
PolandA study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder
PolandA study to evaluate the safety and effectiveness of empasiprubart and efgartigimod alfa in patients with generalized myasthenia gravis.
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on heart failure treatment and prevention, including studies of novel drug combinations like baxdrostat/dapagliflozin and sacubitril/valsartan. Research encompasses various cardiac conditions, from post-myocardial infarction care to atrial fibrillation management.
Multiple studies are examining innovative approaches to cardiac health management and prevention strategies.
Advanced clinical research in multiple sclerosis treatments, testing new therapies like frexalimab and ublituximab. Studies also include innovative approaches to treating Alzheimer's disease and chronic inflammatory demyelinating polyneuropathy.
Trials focus on improving patient outcomes and developing more effective treatment protocols.
Comprehensive studies addressing obesity management and diabetes control, particularly in adolescent populations. Research includes evaluation of new treatments like tirzepatide and innovative insulin therapies.
Research aims to develop more effective treatments for metabolic disorders across different age groups.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
